ReadyStart CleanRooms的动态

If you’re an early-stage company leveraging data to transform human health, there are 101 reasons to join KQ Labs. But if we had to pick just three… 1. Expert mentorship: You will benefit from personalised guidance from a network of hand-picked experts, along with strategic introductions to potential investors. 2. Tailored content: Build on insights from weekly workshops and tailored domain content to grow as a company. 3. Innovative community: Join a community of people driving innovation in data-driven health, a network that will support you even beyond our five-month programme. Don’t miss your chance to be part of KQ Labs ?? ?? Apply now: https://t.ly/ax33L Proudly part of The Francis Crick Institute, with sponsorship from Cancer Research Horizons for one cancer-focused venture. #digitalhealth #drugdiscovery #diagnostics #startups

?? Highlighting the impactful work of Marcus Whitney, founder of Jumpstart Nova — a $55 million fund dedicated to investing in Black-owned healthcare startups. Whitney's mission is to address the neglect of Black innovators in health IT, biotech, and consumer health. He states, “Jumpstart Nova’s strong start validates the need to support solutions from this untapped talent base.” Jumpstart Nova's portfolio tackles issues like equitable access to clinical trials and support for autistic children, with investments requiring a Black founder in a C-level position. For more insights on this article written by Tony O. Lawson of SHOPPE BLACK, read the full article: https://lnkd.in/eEMXVmAs #WeavingImpact #shoppeblack #BlackExcellence #WeavingImpact #HealthcareInnovation #VC #Diversity #Inclusion #EconomicEquity #BlackOwned #JumpstartNova

To all those who are working in health equity and other spaces that are about making the world a little better than we found it. I was recently sharing with another founder an experience I've had (more than once unfortunately). Because we're solving problems created by social inequities, we have had challenging conversations with investors who want to debate that it's a problem to begin with. We recognize that we won't change someone's mind in a 5 minute pitch if they truly have a belief system that obstructs their perceptions, even if we provide the data. But there also are good people who do understand the challenges, who are close to it, making sense of how it fits into their portfolio. I get it, they need to be sure they are making the right investment decision, and not just because they also want things to change. But objectively, this is what we learn about being successful as entrepreneurs: 1) A successful idea/company solves a big problem. For those of us working on maternal health equity alone, this is a $165b problem when you account for the wasted spending on preventable outcomes and the associated economic costs. 2) A successful founder is close to the problem they are solving and passionate about it. We also know that a founder's passion is a key ingredient to success. The founders I know working on health equity don't have a casual interest in the issues. 3) A great solution is disruptive, creating new possibilities to replace old systems. Our healthcare system is plagued with multiple challenges, and old systems are collapsing. This can give rise to new opportunities. I'm looking forward to this event where we can dive right into the solutions. Hope to see you there in September. Thank you Health Care Council of Chicago (HC3) for your invitation and all the work you do to solve for better health care for all. And thank you 2Flo Ventures for this event and your commitment to big ideas solving big problems. https://lnkd.in/g5a9DW8v

The journey of #entrepreneurship is never a straight line, and every step I've taken lately has taught me immensely. From diving back into pitch competitions, engaging deeply in feedback sessions, to strategizing our fundraising efforts (big shoutout to Florian Dostert for the game-changing advice!)—every moment has been a building block. One recurring piece of feedback was clear: we needed more scientific validation for ZenZen Diabetes Support app and proving that we're more than just a concept. That's why being selected for the EIT Health DIGIVITALITY program felt like a significant breakthrough. But the real cherry on top? The feedback from our recent matchmaking sessions! We've just received confirmation that not one, not two, but three major hospitals—the University of Debrecen, General Hospital Murska Sobota, and Charles University Hospital Prague—are interested in collaborating with us. ???? This isn't just a nod of approval but an opportunity to collaborate closely on medical validation, gaining the invaluable feedback we crave. ?? So, here’s a question: Does this selection signal a strong #validation of our project? We're thrilled, but we know the journey of improvement and adaptation never stops. ?? Your thoughts and experiences with similar validation processes would be incredibly helpful. Let's connect and discuss how meaningful partnerships and validation shape the path of health startups like ours! P.S. Thank you for the opportunities to learn: Darya Kamkalova, Ira Philip, Sophie Descollaz, Kevin Withane (FRSA), Juliane Elsner, Ali Ciger #healthtech #startuplife #innovation #eithealth #medicalvalidation #entrepreneurship #diabetes #gestationaldiabetes #pregnancy #metabolichealth #metabolicbalance #zenzenapp

Yesterday was a great day at our Impact AI conference. I ended the day filled with awe at the great entrepreneurs, industry leaders, philanthropists and innovation ecosystem players we have here in Canada. Canada has a foundational role in the development of AI, the most significant technology advancement of our times. We can also play a crucial global role in ensuring the development of it is done in a responsible way focused on some of the critical problems our world is facing. MaRS Discovery District is convening this conversation and working with the whole innovation ecosystem to advance this technology in a responsible manner focused on the public good. Our focus is startups and businesses. Our focus is productivity and economic benefit for Canada. Our focus is commercialization and societal impact. Days like yesterday remind me of how much I love my job.

Recently, the Karen Toffler Charitable Trustheld a dinner as part of the events at Exeloop, where members of our community came together to connect and share ideas to fuel research progress. It became clearer through this discussion that the future of research and innovation holds great promise, with young scientists, advances in genomics, AI, and therapeutic breakthroughs driving progress. As we navigate this future though, we face a complex landscape filled with challenges and opportunities. The critical balance between tradition and modernization, the engagement of young scientists, as well as misinformation and mistrust are among the hurdles that demand our attention. Recognizing the acceleration of scientific progress and the societal role in caring for its members can guide us toward a future where research and innovation continue to thrive. With the right strategies and support, we can look forward to a future of optimism, innovation, and scientific progress. Read more here: #AlzheimersDisease #MedicalResearch

We are celebrating the successful closing of an additional $2.32 Million in Seed Plus funding, closing this round out $500,000 oversubscribed at $5 Million to address underserved #pelvichealth issues. This milestone reflects progress toward our mission to empower women & clinicians with a new gold standard in conservative care for #urinaryincontinence. We extend our deep appreciation to our outstanding partner, Boomerang Ventures for leading this investment round, and we warmly welcome new investors Pier 70 Ventures, Life Science Angels, Orange County Tech Coast Angels MedTech, and Blue Pacific Capital! "Completing this round is an important step in continuing Pelvital's unwavering dedication to provide women with innovative solutions for pelvic health, including the treatment of SUI," says?Lydia Zeller, President and CEO of Pelvital. "This funding will play a crucial role in accelerating our commercialization of Flyte with a strong emphasis on expanding payor coverage, enhancing clinical education and clinician awareness, and advocating for upstream screening for UI in primary care and OB/GYN." With this close we are honored to welcome Preetha Ram, PhD, Managing Partner at Pier 70 Ventures, to the Pelvital Board of Directors. ? "Joining Pelvital's Board alongside this investment round is truly an honor," she shares. "Pier 70 and I are thrilled to be part of this transformational opportunity, as Pelvital's mission aligns beautifully with our dedication to support disruptive technologies that shake up the status quo in healthcare. Pelvital's pioneering work is shaping a future where women's health receives the attention and innovation it deserves with novel medical devices like Flyte." With two published clinical trials validating Flyte's efficacy, we're excited to offer a groundbreaking treatment option for women. Learn more at Flytetherapy.com. #funding #Innovation #WomenInHealthcare Read the full release here: https://lnkd.in/ggkavYRq

EarliTec Diagnostics Secures $21.5M in Series B Funding for Groundbreaking Autism Diagnostic Tool Development! ?? EarliTec Diagnostics, a pioneer in healthcare technology, has successfully raised an impressive $21.5 million in Series B funding. The funding, spearheaded by Nexus NeuroTech Ventures and Venture Investors Health Fund, marks a significant milestone for the company. This substantial investment will propel the commercialization of EarliPoint Evaluation, a cutting-edge diagnostic tool, and will further advance product development initiatives. Notably, the focus will be on pioneering research and development efforts for a revolutionary autism diagnostic and assessment tool tailored for toddlers. Stay tuned for more updates on this game-changing development! #EarliTecDiagnostics #SeriesBFunding #HealthcareInnovation #AutismDiagnosticTool #VentureInvestors #NexusNeuroTechVentures #HealthTechRevolution #EarliPointEvaluation #NewsNowNation ??

Identity Praxis, Inc. we believe in CODE's goals: * Effective data portability * Streamlined consent management * A better deal for consumers * A level playing field * Unlocking new value Achieving these objectives will require us to keep doing some things, do other things differently, and stop doing things altogether. What "things" am I talking about? There are five general categories: 1) economics (esp. business models), 2) industry best practices & regulations/laws, 3) technology (especially fundamental architectures), 4) awareness, culture, and behavior, 5) and politics. There are any number of specifics that we need to tackes within these five categories.

? We are live! As you may know, I’ve been working hard the past few months on Cytonics’ Equity #Crowdfunding campaign with StartEngine. I’m thrilled to let you know that after all this hard work, our campaign is now live and accepting investments! ? ?Complete Your Reservation: https://lnkd.in/eKPXva_y For those who have shown early interest and placed reservations, now’s your chance to complete your investment. Make sure that you complete this within the next two weeks to secure your bonuses (see below)! ?Invitation to New Investors: https://lnkd.in/eiGnJS_q Haven’t invested yet? We want you to join our team. We pride ourselves on having an extremely diverse shareholder base, and one of our goals is to democratize biotech investing, making it accessible to everyone. Visit our campaign page, explore the potential, and make your mark in the fight against osteoarthritis. Remember, with a minimum investment of just $500, you're not only supporting a noble cause but also positioning yourself to reap the rewards of our innovative approach. ??Exclusive Bonuses Await -> Invest within the first 2 weeks and receive bonuses, such as -> Bonus shares (https://lnkd.in/eiGnJS_q) -> One-on-one discussions with our CEO. -> Complementary treatment with our FDA-approved therapy for OA. ?? Your investment in Cytonics isn't just financial; it's a commitment to changing lives. Together, we can offer relief and hope to millions suffering from osteoarthritis. ?? This is a unique opportunity to participate in early-stage #biotechnology research and development. Don't let it slip away. Visit our campaign page now and take the leap into a future where osteoarthritis is a concern of the past. Invest now: https://lnkd.in/eiGnJS_q Meet the Team: Joey Bose | Gaetano Scuderi, MD | Lewis Hanna | Tracy Goeken, M.D. | Phil LoGrasso | Gordon Ramseier #drugdevelopment #investing #osteoarthritis